Clinical presentations and pathophysiological mechanisms of dystroglycanopathy: advancing therapeutic strategies.

Walimbe AS, Muntoni F, Campbell KP.

Open source

DOI
10.1016/s1474-4422(26)00191-2
Published
2026-07-01
Container
Lancet Neurol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-26-00191-2,
  title = {Clinical presentations and pathophysiological mechanisms of dystroglycanopathy: advancing therapeutic strategies.},
  author = {Walimbe AS and  Muntoni F and  Campbell KP.},
  year = {2026},
  journal = {Lancet Neurol},
  doi = {10.1016/s1474-4422(26)00191-2},
  url = {https://doi.org/10.1016/s1474-4422(26)00191-2}
}

RIS

TY  - JOUR
TI  - Clinical presentations and pathophysiological mechanisms of dystroglycanopathy: advancing therapeutic strategies.
AU  - Walimbe AS
AU  -  Muntoni F
AU  -  Campbell KP.
PY  - 2026
JO  - Lancet Neurol
DO  - 10.1016/s1474-4422(26)00191-2
UR  - https://doi.org/10.1016/s1474-4422(26)00191-2
ER  - 

APA

AS, W., F, M., & KP., C. (2026). Clinical presentations and pathophysiological mechanisms of dystroglycanopathy: advancing therapeutic strategies.. Lancet Neurol. https://doi.org/10.1016/s1474-4422(26)00191-2

Source records